miR-215 overexpression distinguishes ampullary carcinomas from pancreatic carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 14, Issue 3, 2015, Pages 325-329

  Choi, Dong Ho ^a   Park, Sang Jae ^b   Kim, Hark Kyun ^b  

^a Hanyang University   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Ampulla of Vater; Gene expression; Pancreatic cancer

Indexed keywords

MICRORNA; MICRORNA 214; MICRORNA 215; MICRORNA 314; UNCLASSIFIED DRUG; MIRN134 MICRORNA, HUMAN; MIRN214 MICRORNA, HUMAN; MIRN215 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PANCREAS CARCINOMA; PRIMARY TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE SIZE; TUMOR DIFFERENTIATION; VATER PAPILLA CARCINOMA; AMPULLA OF VATER; BILE DUCT TUMOR; CARCINOMA; CHEMISTRY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; PANCREAS TUMOR; PATHOLOGY; PREDICTIVE VALUE; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; REPRODUCIBILITY; SECONDARY; UPREGULATION; VALIDATION STUDY;

AGED; AMPULLA OF VATER; BIOMARKERS, TUMOR; CARCINOMA; COMMON BILE DUCT NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; UP-REGULATION;

EID: 84931831784     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(15)60368-X     Document Type: Article

References (8)

1. Fischer HP, Zhou H. Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004;11:301-309.
2. Morini S, Perrone G, Borzomati D, Vincenzi B, Rabitti C, Righi D, et al. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival. Pancreas 2013;42:60-66.
3. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
4. Schultz NA, Werner J, Willenbrock H, Roslind A, Giese N, Horn T, et al. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol 2012;25:1609-1622.
5. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 2010;39:373-384.
6. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, et al. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 2008;68:10094-10104.
7. Joglekar MV, Parekh VS, Hardikar AA. New pancreas from old: microregulators of pancreas regeneration. Trends Endocrinol Metab 2007;18:393-400.
8. Li A, Yu J, Kim H, Wolfgang CL, Canto MI, Hruban RH, et al. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res 2013;19: 3600-3610.